Published • loading... • Updated
Boston Scientific Updates Varithena Prescribing Information for Varicose Vein Treatment
Summary by GeneOnline News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Boston Scientific Updates Varithena Prescribing Information for Varicose Vein Treatment
Boston Scientific Corporation updated the prescribing information for its Varithena (polidocanol) injectable foam on October 12, 2026. The updated documentation outlines the clinical application, safety protocols, and administration guidelines for the treatment, which healthcare providers use to address incompetent veins and visible varicosities of the great saphenous vein system. The updated labeling details the chemical composition of the inje…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
